According to a new study, a new personalized treatment strategy could help treat millions of people living with chronic infections such as HIV, Hepatitis B or Hepatitis C. This study is published in The Journal of Clinical Investigation. Drugs are usually not fully effective for such infections and patients need to deal with long-lasting and costly cures.
By using the viral antigen already present in the blood of the patient suffering from a chronic illness, this strategy redefines therapeutic vaccines by cutting down on time and resources as there is no need to specially isolate the viral proteins from patients, purify it, and then inactivate it to create a vaccine.
Prof Bertoletti said, “Mobilizing the immune system to use the virus within the patient for a vaccine is a simple idea that could lead to a personalized, yet widely applicable, vaccine for chronic infections”.
Prof Judith Swain, Executive Director of SICS said, “This excellent collaborative discovery between SICS and SIgN is a milestone in vaccine therapy for chronic infections. I believe that these findings will go a long way in improving future therapeutic treatments for chronic infections”.
No comments:
Post a Comment